WELLESLEY, Mass.--(BUSINESS WIRE)--Dec. 12, 2003--On December 4, 2003, Form 144 was filed with the Securities and Exchange Commission in error, on behalf of Dr. Marc B. Garnick, Executive Vice President and Chief Medical Officer of Praecis Pharmaceuticals Incorporated (NASDAQ:PRCS - News). A retraction via an amendment to Form 144 has been filed with the Securities and Exchange Commission indicating zero shares to be sold.
Contact:
G.W. & Wade, Inc. Roger W. Wade, 781-239-1188 rwade@gwwade.com
Source: G.W. & Wade, Inc.